Search Result "MEK162"
The Therapeutic Potential of MEK1/2 Inhibitors in the Treatment of Gynecological Cancers: Rational Strategies and Recent Progress
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 6 Year: 2020 Page: 417-428
Author(s): Sadaf Ghanaatgar-Kasbi,Majid Khazaei,Azam Rastgar-Moghadam,Gordon A. Ferns,Seyed Mahdi Hassanian,Amir Avan
Current Therapeutic Leads for the Treatment of Melanoma: Targeted Immunotherapy in the Post-genomic Era
Journal: Current Molecular Pharmacology
Volume: 7 Issue: 1 Year: 2014 Page: 33-43
Author(s): Anastasios D. Papanastasiou,Chaido Sirinian,Haralabos P. Kalofonos,Maria Repanti
Signaling Intermediates (MAPK and PI3K) as Therapeutic Targets in NSCLC
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3944-3957
Author(s): Ludovica Ciuffreda,Ursula Cesta Incani,Linda S. Steelman,Stephen L. Abrams,Italia Falcone,Anais Del Curatolo,William H. Chappell,Richard A. Franklin,Sabrina Vari,Francesco Cognetti,James A. McCubrey,Michele Milella
Signal transduction in Acute Myeloid Leukemia â Implications for Novel Therapeutic Concepts.
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 9 Year: 2015 Page: 803-821
Author(s): Heiko Konig,Cedric Dos Santos
The Therapeutic Promise of Anti-Cancer Drugs Against the Ras/Raf/MEK/ERK Pathway
Ebook: Topics in Anti-Cancer Research
Volume: 2 Year: 2013
Author(s): Erin K. Crane,Kwong-Kwok Wong
Doi: 10.2174/9781608051366113020006
Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 6 Year: 2013 Page: 698-707
Author(s): Vijaya Galic,Robert L. Coleman,Thomas J. Herzog
MAPK Signaling Pathway: A Central Target in Pancreatic Cancer Therapeutics
Ebook: Advances in Cancer Signal Transduction and Therapy
Volume: 1 Year: 2020
Author(s): Sahdeo Prasad,Sanjay K. Srivastava
Doi: 10.2174/9789811458118120010007
Nanocarrier-based Systems for Co-delivery of Drugs in the Managementof Skin Cancer: A Review
Journal: Current Nanomedicine
Volume: 13 Issue: 3 Year: 2023 Page: 188-198
Author(s): Shazia Afzal Usmani
New Treatments for Cutaneous Metastatic Melanoma: MAPK Pathway-Targeted and Immune Based Therapies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 4 Year: 2015 Page: 461-467
Author(s): F. Ranchon,A. Boespflug,C. Rioufol,V. Schwiertz,L. Thomas,S. Dalle
Back to the Bench? MEK and ERK Inhibitors for the Treatment of KRAS Mutant Lung Adenocarcinoma
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 5 Year: 2018 Page: 558-574
Author(s): Jens Kohler,Marco Catalano,Chiara Ambrogio